Dr. Thomas Casciani, MD
Interventional Radiology (Vascular & Interventional Radiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Rochester School of Medicine and Dentistry (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 205
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Rochester School of Medicine and Dentistry
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Vascular & Interventional Radiology Physician primary
IN license 01056406A · IN license 01056406 -
Diagnostic Radiology Physician
IN license 01056406
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Indiana University Health Indianapolis, IN
- Eskenazi Health Indianapolis, IN
- Indiana University Health North Hospital Carmel, IN
- Iu Health West Hospital Avon, IN
Medical groups
- Iu Health Medical Group LLC (4,462 clinicians)
- Indiana University Radiology Associates Inc (178 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 205
- Services billed
- 653
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 87 | 84 |
| Ultrasonic guidance for blood vessel access | 56 | 51 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 53 | 49 |
| Insertion of stomach tube using fluoroscopic guidance with contrast | 25 | 25 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 22 | 22 |
| Removal of tunneled central venous tube | 21 | 20 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 18 | 15 |
| Insertion of central venous tube with port (5 years or older) | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 14 companies reported 69 payments worth $1,356 in total to this clinician.
| Stryker Corporation | $451 |
|---|---|
| Imperative Care, Inc | $246 |
| Angiodynamics, Inc. | $203 |
| Reflow Medical Inc | $86.50 |
| Argon Medical Devices, Inc. | $84.30 |
| Terumo Medical Corporation | $66.76 |
| Penumbra, Inc. | $65.00 |
| Medtronic, Inc. | $28.12 |
| Food and Beverage | $1,356 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $4,800 in research payments for these studies, mostly to the institutions running them.
- The Merit Wrapsody AV Access Efficacy Study
Merit Medical Systems Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.